Journal of the American Chemical Society 2002-10-09

Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors.

Natalie A Dales, Alexandra E Gould, James A Brown, Emily F Calderwood, Bing Guan, Charles A Minor, James M Gavin, Paul Hales, Virendar K Kaushik, Michael Stewart, Peter J Tummino, Chad S Vickers, Timothy D Ocain, Michael A Patane

Index: J. Am. Chem. Soc. 124(40) , 11852-3, (2002)

Full Text: HTML

Abstract

Angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a recently identified zinc metalloprotease with carboxypeptidase activity that was identified using our genomics platform. We implemented a rational design approach to identify potent and selective ACE2 inhibitors. To this end, picomolar inhibitors of ACE2 were designed and synthesized.

Related Compounds

  • 2-Benzylsuccinic a...

Related Articles:

Regulation of cytoplasmic tubulin carboxypeptidase activity in vitro by cations and sulfhydryl-modifying compounds.

1996-03-01

[J. Cell. Biochem. 60(3) , 424-36, (1996)]

Nerve injury evoked loss of latexin expression in spinal cord neurons contributes to the development of neuropathic pain.

2011-01-01

[PLoS ONE 6(4) , e19270, (2011)]

The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen.

1997-12-01

[EMBO J. 16(23) , 6906-13, (1997)]

Bacterial chemotactic oligopeptides and the intestinal mucosal barrier.

1989-07-01

[Gastroenterology 97(1) , 61-7, (1989)]

[Design, synthesis and hypoglycemic activity of alpha-benzylsuccinic acid derivatives].

2009-05-01

[Yao Xue Xue Bao 44(5) , 491-5, (2009)]

More Articles...